- Home
- PAYO vs CERT Comparison
PAYO vs CERT Comparison
Compare PAYO & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYO
- CERT
- Stock Information
- Founded
- PAYO 2005
- CERT 2008
- Country
- PAYO United States
- CERT United States
- Employees
- PAYO N/A
- CERT N/A
- Industry
- PAYO EDP Services
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- PAYO Technology
- CERT Technology
- Exchange
- PAYO Nasdaq
- CERT Nasdaq
- Market Cap
- PAYO 2.1B
- CERT 1.9B
- IPO Year
- PAYO N/A
- CERT 2020
- Fundamental
- Price
- PAYO $5.70
- CERT $12.66
- Analyst Decision
- PAYO Strong Buy
- CERT Buy
- Analyst Count
- PAYO 8
- CERT 8
- Target Price
- PAYO $10.06
- CERT $15.57
- AVG Volume (30 Days)
- PAYO 2.9M
- CERT 1.9M
- Earning Date
- PAYO 11-04-2025
- CERT 11-06-2025
- Dividend Yield
- PAYO N/A
- CERT N/A
- EPS Growth
- PAYO N/A
- CERT N/A
- EPS
- PAYO 0.25
- CERT 0.05
- Revenue
- PAYO $1,017,244,000.00
- CERT $405,755,000.00
- Revenue This Year
- PAYO $9.34
- CERT $11.70
- Revenue Next Year
- PAYO $7.48
- CERT $8.05
- P/E Ratio
- PAYO $23.55
- CERT $254.99
- Revenue Growth
- PAYO 13.02
- CERT 11.61
- 52 Week Low
- PAYO $5.69
- CERT $8.64
- 52 Week High
- PAYO $11.29
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- PAYO 30.98
- CERT 56.04
- Support Level
- PAYO $5.69
- CERT $11.82
- Resistance Level
- PAYO $6.01
- CERT $13.88
- Average True Range (ATR)
- PAYO 0.22
- CERT 0.67
- MACD
- PAYO -0.03
- CERT -0.11
- Stochastic Oscillator
- PAYO 1.43
- CERT 40.63
About PAYO Payoneer Global Inc.
Payoneer Global Inc is a financial technology company purpose-built to enable the world's small and medium-sized businesses (SMB(s)) to grow and operate their businesses around the world by reliably and securely connecting them to the digital economy. The company started to empower commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.